Cite
HARVARD Citation
Padovan, M. et al. (2023). Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series. Expert review of endocrinology & metabolism. 18 (2), pp. 181-198. [Online].